Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Myriad Genetics Inc. (MYGN)

-NasdaqGS
37.97 Down 0.36(0.94%) Apr 17, 4:00PM EDT
|After Hours : 38.00 Up 0.03 (0.08%) Apr 17, 5:48PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2013Jun 30, 2012Jun 30, 2011
Total Revenue 613,165   496,005   402,084  
Cost of Revenue79,618  64,659  46,714  
Gross Profit 533,547   431,346   355,370  
Operating Expenses
Research Development53,706  42,645  27,751  
Selling General and Administrative251,839  208,383  169,841  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 228,002   180,318   157,778  
Income from Continuing Operations
Total Other Income/Expenses Net5,274  4,222  1,873  
Earnings Before Interest And Taxes233,276  184,540  159,651  
Interest Expense -   -   -  
Income Before Tax233,276  184,540  159,651  
Income Tax Expense86,137  72,389  58,941  
Minority Interest -   -   -  
Net Income From Continuing Ops147,139  112,151  100,710  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 147,139   112,151   100,710  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 147,139   112,151   100,710  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.